1 / 1

Supplementary Figure 1

A. ZVAD -. ZVAD +. 0 6 12 0 6 12 hr. FL CL. Caspase-8. FL CL. Caspase-9. FL CL. Caspase-3. FL CL. PARP. α-Tubulin. B. C. control. control. ZVAD 25 μM. ZVAD 50 μM. ZVAD 50 μM. 120. 100. 90. 100. 80. 70. 80. % Control. % Positive Cells. 60. 60. 50. 40. 40.

teo
Download Presentation

Supplementary Figure 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A ZVAD - ZVAD + 0 6 12 0 6 12 hr FL CL Caspase-8 FL CL Caspase-9 FL CL Caspase-3 FL CL PARP α-Tubulin B C control control ZVAD 25μM ZVAD 50μM ZVAD 50μM 120 100 90 100 80 70 80 % Control % Positive Cells 60 60 50 40 40 30 20 20 10 0 0 0 6.25 12.5 25 50 100 0 25 50 Cerulenin μM Cerulenin μM • Supplementary Figure 1. Cerulenin induces apoptosis in U266 cells • U266 cells were cultured with Cerulenin (50 M) for the indicated times, with or • without Z-VAD-FMK (50 M) for 1 hour pretreatment. Total cell lysates (20 g /lane) • were subjected to Western blotting using anti-caspase -8, -9, -3, PARP, and α-tubulin • Abs. FL, CF indicated as full length and cleaved form, respectively. (B) (C) U266 cells • were treated with indicated dose of Cerulenin for 24 hours, with or without Z-VAD-FMK • (25 M or 50 M) 1 hour pretreatment. Cytotoxicity was determined by MTT assay (B). • Values represent mean  SD of quadruplicate cultures. The percentage apoptotic cells • was determined by flow-cytometric analysis for APO2.7 staining (C). Supplementary Figure 1

More Related